Literature DB >> 18498296

Investigation of killer cell immunoglobulin-like receptor (KIR) gene diversity: KIR2DL2, KIR2DL5 and KIR2DS5.

A Gonzalez1, A Meenagh, C Sleator, D Middleton.   

Abstract

Human killer cell immunoglobulin-like receptor (KIR) genes are important for restraining natural killer cytotoxicity toward cells with autologous human leukocyte antigen (HLA) while targeting cells lacking or expressing low levels of self-HLA molecules. KIR gene content and alleles vary across individual genomes and populations, requiring specialized laboratory tools for their characterization. Here, we detail methods based on sequence-specific polymerase chain reaction amplification and oligonucleotide probe hybridization to identify alleles of KIR2DL2, KIR2DL5A, KIR2DL5B and KIR2DS5. Allele frequencies for a Northern Irish population of 354 individuals typed with this system are given, along with results from 132 cell lines from the International Histocompatibility Workshop that cover many world populations. This information complements published reports by our laboratory for allele-level typing of other KIR members, totaling 12 of the 17 known genes. These methods are allowing us to characterize KIR haplotypes in our population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498296     DOI: 10.1111/j.1399-0039.2008.01050.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

Review 2.  The extensive polymorphism of KIR genes.

Authors:  Derek Middleton; Faviel Gonzelez
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

3.  Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome.

Authors:  Jose Ramón Vidal-Castiñeira; Antonio López-Vázquez; Jesús Martínez-Borra; Pablo Martínez-Camblor; Jesús Prieto; Rosario López-Rodríguez; Paloma Sanz-Cameno; Juan de la Vega; Luis Rodrigo; Rosa Pérez-López; Ramón Pérez-Álvarez; Carlos López-Larrea
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

4.  Association of maternal KIR gene content polymorphisms with reduction in perinatal transmission of HIV-1.

Authors:  Yusuf O Omosun; Anna J Blackstock; John Williamson; Anne Maria van Eijk; John Ayisi; Juliana Otieno; Renu B Lal; Feiko O Ter Kuile; Laurence Slutsker; Ya Ping Shi
Journal:  PLoS One       Date:  2018-01-23       Impact factor: 3.240

5.  Killer Immunoglobulin-Like Receptor Allele Determination Using Next-Generation Sequencing Technology.

Authors:  Bercelin Maniangou; Nolwenn Legrand; Mehdi Alizadeh; Ulysse Guyet; Catherine Willem; Gaëlle David; Eric Charpentier; Alexandre Walencik; Christelle Retière; Katia Gagne
Journal:  Front Immunol       Date:  2017-05-19       Impact factor: 7.561

6.  Allele-Level KIR Genotyping of More Than a Million Samples: Workflow, Algorithm, and Observations.

Authors:  Ines Wagner; Daniel Schefzyk; Jens Pruschke; Gerhard Schöfl; Bianca Schöne; Nicole Gruber; Kathrin Lang; Jan Hofmann; Christine Gnahm; Bianca Heyn; Wesley M Marin; Ravi Dandekar; Jill A Hollenbach; Johannes Schetelig; Julia Pingel; Paul J Norman; Jürgen Sauter; Alexander H Schmidt; Vinzenz Lange
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

7.  Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.

Authors:  Cynthia Vierra-Green; David Roe; Lihua Hou; Carolyn Katovich Hurley; Raja Rajalingam; Elaine Reed; Tatiana Lebedeva; Neng Yu; Mary Stewart; Harriet Noreen; Jill A Hollenbach; Lisbeth A Guethlein; Tao Wang; Stephen Spellman; Martin Maiers
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

8.  KIR2DL5: An Orphan Inhibitory Receptor Displaying Complex Patterns of Polymorphism and Expression.

Authors:  Elisa Cisneros; Manuela Moraru; Natalia Gómez-Lozano; Miguel López-Botet; Carlos Vilches
Journal:  Front Immunol       Date:  2012-09-17       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.